Revolutionising Vein Treatment: The Power of Ultrasound-Guided Foam Sclerotherapy and Varixio

Let's face it: varicose veins, spider veins, and other venous issues are not only unsightly, but they can also be painful and lead to serious health complications.

While various treatments exist, such as glue, endothermal ablation with laser and radiofrequency and mechanochemical ablation (MOCA) there's one method that stands head and shoulders above the rest in terms of effectiveness and versatility: FOAM SCLEROTHERAPY.

The Catch: Traditional Foam Sclerotherapy has not been widely adopted by vein specialists

But here's the problem: traditional foam sclerotherapy, while highly effective, has historically been hampered by perceived inconsistencies in foam quality, an erroneous view that foam sclerotherapy is less effective than laser and radiofrequency ablation and concerns about potential complications associated with the air used in the Tessari Method.

These opinions have limited its widespread adoption and left many patients seeking alternatives.

The Solution: A Standardised Protocol for Ultrasound-Guided Foam Sclerotherapy with Varixio

Enter a standardised approach to ultrasound-guided foam sclerotherapy (UGFS), that combines the power of FOAM SCLEROTHERAPY with the precision of ultrasound imaging and production of high quality foam using VARIXIO.

UGFS allows for accurate targeting of problematic veins, ensuring optimal delivery of the FOAM SCLEROSANT.

The introduction of the Varixio device has the potential to enable UGFS to become even more accessible and effective.

Varixio is an automated system that produces high-quality foam sclerosant with consistent bubble size and stability. This ensures reliable results and may reduce the risk of adverse events associated with traditional manual foam preparation.

AND VARIXIO ALLOWs THE CONVENIENT PRODUCTION OF FOAM WITH PHYSIOLOGICAL GASES.

Why Ultrasound-Guided Foam Sclerotherapy is the Only Solution

UGFS is the only treatment that can address the full spectrum of venous issues, from tiny spider veins to large varicose veins and even complex recurrent veins. Its versatility and effectiveness make it the ideal FIRST LINE TREATMENT for most patients.

But it's not just about treating VISIBLE veins. UGFS has the potential to tackle the root cause of many venous problems: superficial venous reflux. By addressing this underlying issue, UGFS can minimise the recurrence of varicose veins and reduce the risk of complications like leg ulcers.

Key Takeaways:

1. Unmatched Versatility: UGFS can treat a wide range of venous issues, from spider veins to large varicose veins and superficial venous reflux.

2. Superior Efficacy: Foam sclerotherapy has been shown to be more effective than liquid sclerotherapy, and the Varixio device MAY further enhance its effectiveness.

3. Minimised Risks: UGFS with Varixio MAY reduce the risk of complications associated with traditional foam preparation.

4. Targeted Treatment: Ultrasound guidance ensures precise delivery of the sclerosing agent, minimising damage to surrounding tissues.

5. Preventive Potential: By addressing superficial venous reflux, UGFS can minimise the recurrence of varicose veins and reduce the risk of complications.

6. Technical Simplicity and Low Cost: Capital and running costs are low and with proper training, UGFS is easy to incorporate into a vein practice.

If you treat varicose veins or other venous issues, learn more by watching Enric Roche in action.

Ultrasound-guided foam sclerotherapy with Varixio may be the future of vein care, offering a safe, effective, and minimally invasive solution for healthier legs.

Watch this video in which Enric Roche describes his Ultrasound Guided Foam Sclerotherapy Protocol and the use of Varixio.